Evaluation of the Effects of the Low-level Laser Therapy as an Adjunct to Nonsurgical Treatment in Patients With Periimplantitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMustafa Kemal University

About this trial

The main objective of this study is to evaluate the clinical efficacy of low-level laser therapy (LLLT) in addition to non-surgical periodontal treatment in patients with peri-implantitis. The study aims to investigate the anti-inflammatory and regenerative effects of low-level laser therapy on peri-implant soft and hard tissues and to reveal its contribution to treatment success.

In this context, the specific objectives of the study are as follows:

1. To evaluate the effects of LLLT added to non-surgical mechanical treatment on clinical parameters such as plaque index, probing depth, bleeding index, and clinical attachment level. 2. To examine the contributions of laser therapy to tissue healing by analyzing biochemical markers in peri-implant sulcular fluid over time.

Eligibility criteria

Qualifiers

The patient must be willing to participate in the study.

At least one implant with a pocket depth ≥ 6 mm and radiographic bone loss ≥ 3 mm diagnosed with peri-implantitis.

Individuals aged 18-65.

Patients who can understand and maintain oral hygiene education.

Disqualifiers

Individuals with any systemic disease that affects periodontal healing (diabetes, cancer, HIV/AIDS, acute infections, liver or kidney dysfunction/insufficiency, autoimmune disorders: rheumatoid arthritis, systemic lupus erythematosus, Hashimoto's thyroiditis)

Female patients who are pregnant or breastfeeding

Patients who have undergone periodontal treatment within the last six months

Patients who have used antibiotics and regular anti-inflammatory medications within the last six months

Trial design

Treatments tested in this trial

  • Low Level Laser Therapy
  • Non-surgical Periodontal Treatment

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators